ENST00000636768.2:n.*1929C>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000636768.2(CACNA1A):n.*1929C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 896,776 control chromosomes in the GnomAD database, including 90,744 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.48 ( 17903 hom., cov: 29)
Exomes 𝑓: 0.44 ( 72841 hom. )
Consequence
CACNA1A
ENST00000636768.2 non_coding_transcript_exon
ENST00000636768.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0930
Publications
16 publications found
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 19-13207166-G-T is Benign according to our data. Variant chr19-13207166-G-T is described in ClinVar as [Benign]. Clinvar id is 1292948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000636768.2 | n.*1929C>A | non_coding_transcript_exon_variant | Exon 45 of 45 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000713789.1 | n.*2847C>A | non_coding_transcript_exon_variant | Exon 47 of 47 | ENSP00000519091.1 | |||||
CACNA1A | ENST00000360228.11 | c.*147C>A | 3_prime_UTR_variant | Exon 47 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | |||
CACNA1A | ENST00000637769.1 | c.*147C>A | 3_prime_UTR_variant | Exon 47 of 47 | 1 | ENSP00000489778.1 | ||||
CACNA1A | ENST00000637736.1 | c.*147C>A | 3_prime_UTR_variant | Exon 46 of 46 | 5 | ENSP00000489861.1 | ||||
CACNA1A | ENST00000636389.1 | c.*754C>A | 3_prime_UTR_variant | Exon 47 of 47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000635895.1 | c.*880C>A | 3_prime_UTR_variant | Exon 47 of 47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009.2 | c.*880C>A | 3_prime_UTR_variant | Exon 47 of 47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000636768.2 | n.*1929C>A | 3_prime_UTR_variant | Exon 45 of 45 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000713789.1 | n.*2847C>A | 3_prime_UTR_variant | Exon 47 of 47 | ENSP00000519091.1 | |||||
CACNA1A | ENST00000638029.1 | c.*147C>A | downstream_gene_variant | 5 | ENSP00000489829.1 | |||||
CACNA1A | ENST00000573710.7 | c.*147C>A | downstream_gene_variant | 5 | ENSP00000460092.3 | |||||
CACNA1A | ENST00000635727.1 | c.*147C>A | downstream_gene_variant | 5 | ENSP00000490001.1 | |||||
CACNA1A | ENST00000636012.1 | c.*147C>A | downstream_gene_variant | 5 | ENSP00000490223.1 | |||||
CACNA1A | ENST00000637432.1 | c.*880C>A | downstream_gene_variant | 5 | ENSP00000490617.1 |
Frequencies
GnomAD3 genomes AF: 0.480 AC: 72581AN: 151216Hom.: 17877 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
72581
AN:
151216
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.437 AC: 325472AN: 745448Hom.: 72841 Cov.: 10 AF XY: 0.443 AC XY: 166138AN XY: 375138 show subpopulations
GnomAD4 exome
AF:
AC:
325472
AN:
745448
Hom.:
Cov.:
10
AF XY:
AC XY:
166138
AN XY:
375138
show subpopulations
African (AFR)
AF:
AC:
7945
AN:
13572
American (AMR)
AF:
AC:
6168
AN:
11536
Ashkenazi Jewish (ASJ)
AF:
AC:
6759
AN:
12866
East Asian (EAS)
AF:
AC:
8397
AN:
23874
South Asian (SAS)
AF:
AC:
28474
AN:
48284
European-Finnish (FIN)
AF:
AC:
11567
AN:
28278
Middle Eastern (MID)
AF:
AC:
1391
AN:
2434
European-Non Finnish (NFE)
AF:
AC:
239339
AN:
571146
Other (OTH)
AF:
AC:
15432
AN:
33458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
8733
17465
26198
34930
43663
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.480 AC: 72659AN: 151328Hom.: 17903 Cov.: 29 AF XY: 0.482 AC XY: 35633AN XY: 73972 show subpopulations
GnomAD4 genome
AF:
AC:
72659
AN:
151328
Hom.:
Cov.:
29
AF XY:
AC XY:
35633
AN XY:
73972
show subpopulations
African (AFR)
AF:
AC:
23693
AN:
41278
American (AMR)
AF:
AC:
7723
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
1835
AN:
3464
East Asian (EAS)
AF:
AC:
1889
AN:
5120
South Asian (SAS)
AF:
AC:
2800
AN:
4796
European-Finnish (FIN)
AF:
AC:
4357
AN:
10430
Middle Eastern (MID)
AF:
AC:
188
AN:
290
European-Non Finnish (NFE)
AF:
AC:
28717
AN:
67710
Other (OTH)
AF:
AC:
1103
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1841
3682
5523
7364
9205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1915
AN:
3470
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.